• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

STAT3 诱导的长链非编码 RNA ABHD11-AS1 的上调通过调节 miR-1301-3p/STAT3 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌的肿瘤进展。

STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.

机构信息

Department of Radiation and Oncology, Navy General Hospital, Beijing, China.

Department of Neurosurgery, Navy General Hospital, Beijing, China.

出版信息

Cell Prolif. 2019 Mar;52(2):e12569. doi: 10.1111/cpr.12569. Epub 2019 Jan 18.

DOI:10.1111/cpr.12569
PMID:30657221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6495520/
Abstract

OBJECTIVES

Emerging evidences indicated the importance of long non-coding RNAs (lncRNAs) in the tumorigenesis and deterioration of malignant tumours. To our knowledge, the study about lncRNAs in papillary thyroid carcinoma (PTC) is still inadequate. ABHD11-AS1 was highly expressed in the PTC samples of The Cancer Genome Atlas database. This study focused on the biological function and mechanism of lncRNA ABHD11-AS1 in PTC.

MATERIALS AND METHODS

qRT-PCR analysis was used to examine the expression of ABHD11-AS1 in PTC tissues and cell lines. The prognostic significance of ABHD11-AS1 for the patients with PTC was analysed with Kaplan-Meier analysis. The effects of ABHD11-AS1 knockdown on the cell proliferation and metastasis were evaluated by in vitro functional assays and in vivo experiments. The molecular mechanism which contributed to the oncogenic role of ABHD11-AS1 in PTC was explored by conducting mechanism experiments. Rescue assays were carried out for final demonstration.

RESULTS

High expression of ABHD11-AS1 predicted poor prognosis for patients with PTC and promoted cell proliferation and metastasis in vitro and in vivo. ABHD11-AS1 was activated by the transcription factor STAT3. ABHD11-AS1 positively regulated PI3K/AKT signalling pathway. ABHD11-AS1 acted as a competitive endogenous (ce) RNA to upregulate STAT3 by sponging miR-1301-3p.

CONCLUSIONS

STAT3-induced lncRNA ABHD11-AS1 promoted PTC progression by regulating PI3K/AKT signalling pathway and miR-1301-3p/STAT3 axis.

摘要

目的

越来越多的证据表明长链非编码 RNA（lncRNA）在肿瘤的发生和恶性肿瘤的恶化中起着重要作用。据我们所知，lncRNA 在甲状腺乳头状癌（PTC）中的研究仍不够充分。ABHD11-AS1 在癌症基因组图谱数据库的 PTC 样本中表达较高。本研究集中于 lncRNA ABHD11-AS1 在 PTC 中的生物学功能和机制。

材料和方法

qRT-PCR 分析用于检测 PTC 组织和细胞系中 ABHD11-AS1 的表达。Kaplan-Meier 分析用于分析 ABHD11-AS1 对 PTC 患者的预后意义。通过体外功能测定和体内实验评估 ABHD11-AS1 敲低对细胞增殖和转移的影响。通过进行机制实验探索有助于 ABHD11-AS1 在 PTC 中致癌作用的分子机制。进行挽救实验以最终证明。

结果

ABHD11-AS1 的高表达预测 PTC 患者预后不良，并在体外和体内促进细胞增殖和转移。ABHD11-AS1 由转录因子 STAT3 激活。ABHD11-AS1 正向调节 PI3K/AKT 信号通路。ABHD11-AS1 通过海绵 miR-1301-3p 作为竞争性内源性（ce）RNA 来上调 STAT3。

结论

STAT3 诱导的 lncRNA ABHD11-AS1 通过调节 PI3K/AKT 信号通路和 miR-1301-3p/STAT3 轴促进 PTC 进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/7314dcf1f836/CPR-52-e12569-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/7daa883c001b/CPR-52-e12569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/8b0c0591822f/CPR-52-e12569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/71c095dd762e/CPR-52-e12569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/342b8c3d932a/CPR-52-e12569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/1803386a9d94/CPR-52-e12569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/7314dcf1f836/CPR-52-e12569-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/7daa883c001b/CPR-52-e12569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/8b0c0591822f/CPR-52-e12569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/71c095dd762e/CPR-52-e12569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/342b8c3d932a/CPR-52-e12569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/1803386a9d94/CPR-52-e12569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/6495520/7314dcf1f836/CPR-52-e12569-g008.jpg

相似文献

1
STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.STAT3 诱导的长链非编码 RNA ABHD11-AS1 的上调通过调节 miR-1301-3p/STAT3 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌的肿瘤进展。
Cell Prolif. 2019 Mar;52(2):e12569. doi: 10.1111/cpr.12569. Epub 2019 Jan 18.
2
Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.长链非编码 RNA TTN-AS1 通过调节 miR-153-3p/ZNRF2 轴促进甲状腺乳头状癌的发生。
J Gene Med. 2019 May;21(5):e3083. doi: 10.1002/jgm.3083. Epub 2019 Mar 25.
3
Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.长链非编码 RNA ABHD11-AS1 通过 miR-199a-5p/SLC1A5 轴作为竞争性内源性 RNA 调节甲状腺乳头状癌的进展。
Cell Death Dis. 2019 Aug 14;10(8):620. doi: 10.1038/s41419-019-1850-4.
4
LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.长链非编码 RNA ABHD11-AS1 通过调节 EPS15L1/EGFR 信号通路促进甲状腺乳头状癌的肿瘤进展。
Clin Transl Oncol. 2022 Jun;24(6):1124-1133. doi: 10.1007/s12094-021-02753-z. Epub 2022 Jan 31.
5
Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.长链非编码 RNA ASMTL-AS1 通过调控 miR-93-3p/miR-660/FOXO1 轴抑制甲状腺乳头状癌肿瘤生长和糖酵解。
Life Sci. 2020 Mar 1;244:117298. doi: 10.1016/j.lfs.2020.117298. Epub 2020 Jan 14.
6
Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.血清 lncRNA-ABHD11-AS1 过表达与甲状腺乳头状癌患者预后不良相关。
Exp Mol Pathol. 2021 Aug;121:104658. doi: 10.1016/j.yexmp.2021.104658. Epub 2021 Jun 6.
7
A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.一种新的长链非编码 RNA n384546 通过作为 miR-145-5p 的竞争性内源性 RNA 来调节 AKT3，促进甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.
8
METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.METTL14 通过调节长链非编码 RNA OIP5-AS1/miR-98/ADAMTS8 信号通路促进甲状腺乳头状癌的发生。
Cell Death Dis. 2021 Jun 15;12(6):617. doi: 10.1038/s41419-021-03891-6.
9
The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.DLG1-AS1/miR-497/YAP1 轴调控甲状腺乳头状癌细胞的进展。
Aging (Albany NY). 2020 Nov 16;12(22):23326-23336. doi: 10.18632/aging.104121.
10
Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.DLG1-AS1 的异常表达可将甲状腺乳头状癌与良性甲状腺结节区分开来。
BMC Endocr Disord. 2019 Nov 12;19(1):122. doi: 10.1186/s12902-019-0440-x.

引用本文的文献

1
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors.甲状腺乳头状癌相关长链非编码RNA及其与恶性肿瘤相关性的叙述性综述
Transl Cancer Res. 2025 Mar 30;14(3):2125-2149. doi: 10.21037/tcr-24-1038. Epub 2025 Mar 27.
2
LncRNA ABHD11-AS1 Elevates CALM2 to Promote Metastasis of Thyroid Cancer Through Sponging miR-876-5p.长链非编码RNA ABHD11-AS1通过吸附miR-876-5p上调钙调蛋白2以促进甲状腺癌转移。
Biochem Genet. 2025 Mar 21. doi: 10.1007/s10528-025-11072-9.
3
Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

本文引用的文献

1
Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis.长链非编码 RNA CASC9/miR-519d/STAT3 正反馈环促进胶质瘤发生。
J Cell Mol Med. 2018 Dec;22(12):6338-6344. doi: 10.1111/jcmm.13932. Epub 2018 Sep 30.
2
LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.长链非编码 RNA HOXA11-AS 通过调节 miR-454-3p/Stat3 驱动人 LUAD 细胞对顺铂的耐药性。
Cancer Sci. 2018 Oct;109(10):3068-3079. doi: 10.1111/cas.13764. Epub 2018 Sep 2.
3
Identification and Functional Characterization of Long Non-coding RNA as a Tumor Suppressor for Hepatocellular Carcinoma.
靶向细胞外基质硬度的协同抗癌策略：原发性肝癌中基质软化与机械信号转导阻断的整合
Adv Sci (Weinh). 2025 Feb;12(6):e2403040. doi: 10.1002/advs.202403040. Epub 2024 Dec 20.
4
LncRNA CASC9 facilitates papillary thyroid cancer development and doxorubicin resistance via miR-28-3p/BCL-2 axis and PI3K/AKT signaling pathway.长链非编码 RNA CASC9 通过 miR-28-3p/BCL-2 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌细胞的发展和多柔比星耐药性。
J Cardiothorac Surg. 2024 Nov 13;19(1):629. doi: 10.1186/s13019-024-03129-4.
5
The association between long noncoding RNA ABHD11-AS1 and malignancy prognosis: a meta-analysis.长链非编码 RNA ABHD11-AS1 与恶性肿瘤预后的相关性：一项荟萃分析。
BMC Cancer. 2024 Sep 2;24(1):1083. doi: 10.1186/s12885-024-12866-7.
6
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks.甲状腺乳头状癌的高侵袭性：从临床证据到调控细胞网络
Cell Death Discov. 2024 Aug 26;10(1):378. doi: 10.1038/s41420-024-02157-2.
7
Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer.成像技术与生化生物标志物：胰腺癌诊断的新见解
Cell Biochem Biophys. 2024 Dec;82(4):3123-3144. doi: 10.1007/s12013-024-01437-z. Epub 2024 Jul 19.
8
Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis.长链非编码 RNA ABHD11-AS1 与 SART3 相互作用，调节 CD44 RNA 可变剪接，促进肺癌发生。
Environ Int. 2024 Mar;185:108494. doi: 10.1016/j.envint.2024.108494. Epub 2024 Feb 10.
9
Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.用于甲状腺乳头状癌诊断和预后的微小RNA差异表达
Front Med (Lausanne). 2023 Apr 5;10:1139362. doi: 10.3389/fmed.2023.1139362. eCollection 2023.
10
SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53.SNRPB通过抑制p53促进甲状腺癌的细胞周期进程。
Open Med (Wars). 2022 Oct 18;17(1):1623-1631. doi: 10.1515/med-2022-0531. eCollection 2022.
鉴定和功能表征长链非编码 RNA 作为肝癌的肿瘤抑制因子。
Theranostics. 2018 Jun 13;8(14):3751-3765. doi: 10.7150/thno.22493. eCollection 2018.
4
Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128.长链非编码 RNA PVT1-214 通过稳定 Lin28 并与 miR-128 相互作用促进结直肠癌的增殖和侵袭。
Oncogene. 2019 Jan;38(2):164-179. doi: 10.1038/s41388-018-0432-8. Epub 2018 Aug 3.
5
The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.长链非编码 RNA CYTOR 通过与 NCL 和 Sam68 相互作用促进结直肠癌的进展。
Mol Cancer. 2018 Jul 31;17(1):110. doi: 10.1186/s12943-018-0860-7.
6
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.风险 SNP 介导的启动子-增强子转换通过 lncRNA PCAT19 驱动前列腺癌。
Cell. 2018 Jul 26;174(3):564-575.e18. doi: 10.1016/j.cell.2018.06.014. Epub 2018 Jul 19.
7
LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.LINC01638 lncRNA 通过阻止 SPOP 介导的 c-Myc 降解激活三阴性乳腺癌中的 MTDH-Twist1 信号通路。
Oncogene. 2018 Nov;37(47):6166-6179. doi: 10.1038/s41388-018-0396-8. Epub 2018 Jul 12.
8
LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells.LINC01287/miR-298/STAT3 反馈环路调控肝癌细胞的生长和上皮间质转化表型。
J Exp Clin Cancer Res. 2018 Jul 13;37(1):149. doi: 10.1186/s13046-018-0831-2.
9
Long non-coding RNA lnc-PCTST predicts prognosis through inhibiting progression of pancreatic cancer by downregulation of TACC-3.长链非编码RNA lnc-PCTST通过下调TACC-3抑制胰腺癌进展来预测预后。
Int J Cancer. 2018 Dec 15;143(12):3143-3154. doi: 10.1002/ijc.31657. Epub 2018 Nov 15.
10
LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR-520d-3p/STAT3 axis.长链非编码RNA SNHG16通过调控miR-520d-3p/STAT3轴驱动血管瘤内皮细胞的增殖、迁移和侵袭。
Cancer Med. 2018 Jul;7(7):3311-3320. doi: 10.1002/cam4.1562. Epub 2018 May 29.